Literature DB >> 29482434

An index of fatal toxicity for new psychoactive substances.

Leslie A King1, John M Corkery2.   

Abstract

An index of fatal toxicity for new psychoactive substances has been developed based solely on information provided on death certificates. An updated index of fatal toxicity (Tf), as first described in 2010, was calculated based on the ratio of deaths to prevalence and seizures for the original five substances (amphetamine, cannabis, cocaine/crack, heroin and 3,4-methylenedioxymethylamphetamine)*. These correlated well with the 2010 index. Deaths were then examined for cases both where the substance was and was not found in association with other substances. This ratio (sole to all mentions; S/A) was then calculated for deaths in the period 1993 to 2016. This new measure of fatal toxicity, expressed by S/A, was well-correlated with the index Ln (Tf) of the original reference compounds. The calculation of S/A was then extended to a group of new psychoactive substances where insufficient prevalence or seizure data were available to directly determine a value of Tf by interpolation of a graph of Tf versus S/A. Benzodiazepine analogues had particularly low values of S/A and hence Tf. By contrast, γ-hydroxybutyrate/γ-butyrolactone, α-methyltryptamine, synthetic cannabinoid receptor agonists and benzofurans had a higher fatal toxicity.

Entities:  

Keywords:  Mortality statistics; availability; drug users; legal highs; new psychoactive substances; prevalence

Mesh:

Substances:

Year:  2018        PMID: 29482434     DOI: 10.1177/0269881118754709

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  7 in total

1.  Structure-activity relationships of bath salt components: substituted cathinones and benzofurans at biogenic amine transporters.

Authors:  Amy J Eshleman; Shanthi Nagarajan; Katherine M Wolfrum; John F Reed; Tracy L Swanson; Aaron Nilsen; Aaron Janowsky
Journal:  Psychopharmacology (Berl)       Date:  2018-11-05       Impact factor: 4.530

2.  The relative lethal toxicity of pharmaceutical and illicit substances: A 16-year study of the Greater Newcastle Hunter Area, Australia.

Authors:  Jonathan Brett; Claire E Wylie; Jacques Raubenheimer; Geoff K Isbister; Nick A Buckley
Journal:  Br J Clin Pharmacol       Date:  2019-07-17       Impact factor: 4.335

Review 3.  How deaths can help clinicians and policy-makers understand the risks of novel psychoactive substances.

Authors:  John Martin Corkery; Fabrizio Schifano; Giovanni Martinotti
Journal:  Br J Clin Pharmacol       Date:  2020-01-14       Impact factor: 4.335

4.  Comparative Neuropharmacology and Pharmacokinetics of Methamphetamine and Its Thiophene Analog Methiopropamine in Rodents.

Authors:  Silja Skogstad Tuv; Marianne Skov-Skov Bergh; Jannike Mørch Andersen; Synne Steinsland; Vigdis Vindenes; Michael H Baumann; Marilyn A Huestis; Inger Lise Bogen
Journal:  Int J Mol Sci       Date:  2021-11-05       Impact factor: 5.923

5.  Alprazolam-related deaths in Scotland, 2004-2020.

Authors:  John Martin Corkery; Amira Guirguis; Stefania Chiappini; Giovanni Martinotti; Fabrizio Schifano
Journal:  J Psychopharmacol       Date:  2022-08-01       Impact factor: 4.562

Review 6.  Fatal and non-fatal health incidents related to recreational ecstasy use.

Authors:  Jan van Amsterdam; Ed Pennings; Wim van den Brink
Journal:  J Psychopharmacol       Date:  2020-01-07       Impact factor: 4.153

7.  Recreational ketamine-related deaths notified to the National Programme on Substance Abuse Deaths, England, 1997-2019.

Authors:  John Martin Corkery; Wan-Chu Hung; Hugh Claridge; Christine Goodair; Caroline S Copeland; Fabrizio Schifano
Journal:  J Psychopharmacol       Date:  2021-06-05       Impact factor: 4.153

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.